Some of these issues could be alleviated with robust human-based research, followed by FDA approval if warranted
Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to AOD-9604 research
This includes those with conditions like pernicious anemia, certain gastrointestinal disorders, or age-related absorption issues
MOTS-c (intermittent) is 2-3 injections per week starting Week 5
[DOI] [PMC free article] [PubMed] [Google Scholar] 87.Konosic S., Petricevic M., Ivancan V., Konosic L., Goluza E., Krtalic B., Drmic D., Stupnisek M., Seiwerth S., Sikiric P
Most BPC-157 research concerns the peptide generally and does not compare arginate with acetate